MISSISSAUGA, ON, Feb. 26, 2021 /PRNewswire/ – Covalon Applied sciences Ltd. (the “Firm” or “Covalon”) (TSXV: COV) (OTCQX: CVALF), a complicated medical applied sciences firm, will launch its fiscal 2021 first quarter monetary outcomes on Monday March 1st 2021 earlier than markets open. A convention name to debate the monetary outcomes will likely be held on Monday March 1st 2021 at 9:00am EST. To take part within the convention name, please dial:
Native (Toronto): 416.764.8659
North American Toll Free: 1.888.664.6392
Affirmation Quantity: 13753009
A recording of the decision will likely be out there by calling 416.764.8677 or 1.888.390.0541 and getting into the encore replay entry code 753009# from March 1st 2021 at 12:00pm EST to March 15th 2021 at 11:59pm EST. A recording of the decision will likely be out there on www.covalon.com on the Occasions web page below Information & Occasions on the Buyers tab.
Covalon Applied sciences Ltd. is a researcher, developer, producer, and marketer of patent-protected medical merchandise that enhance affected person outcomes and save lives within the areas of superior wound care, an infection administration and surgical procedures. Covalon leverages its patented medical know-how platforms and experience in two methods: (i) by growing merchandise which can be bought below Covalon’s title; and (ii) by growing and commercializing medical merchandise for different medical corporations below improvement and license contracts. The Firm is listed on the TSX Enterprise Change, having the image COV and trades on the OTQX Market below the image CVALF. To be taught extra about Covalon, go to our web site at www.covalon.com.
Neither TSX Enterprise Change nor its Regulation Providers Supplier (as that time period is outlined within the insurance policies of the TSX Enterprise Change) accepts duty for the adequacy or accuracy of this launch.
This information launch incorporates forward-looking statements which mirror the Firm’s present expectations concerning future occasions. The forward-looking statements are sometimes, however not all the time, recognized by means of phrases comparable to “search”, “anticipate”, “plan, “estimate”, “count on”, “intend” and statements that an occasion or consequence “could”, “will”, “ought to”, “may” or “may” happen or be achieved and different comparable expressions. These forward-looking statements contain threat and uncertainties, together with completion of integration of the AquaGuard acquisition, the issue in predicting product approvals, acceptance of and calls for for brand spanking new merchandise, the impression of the merchandise and pricing methods of opponents, delays in growing and launching new merchandise, the regulatory surroundings, fluctuations in working outcomes, the impression and timing of COVID-19 on working actions and market situations, and different dangers, any of which may trigger outcomes, efficiency, or achievements to vary materially from the outcomes mentioned or implied within the forward-looking statements. Many dangers are inherent within the trade; others are extra particular to the Firm. Buyers ought to seek the advice of the Firm’s ongoing quarterly filings for extra data on dangers and uncertainties relating to those forward-looking statements. Buyers shouldn’t place undue reliance on any forward-looking statements. The Firm assumes no obligation to replace or alter any forward-looking statements whether or not on account of new data, additional occasions or in any other case.
View authentic content material to obtain multimedia:http://www.prnewswire.com/news-releases/covalon-announces-conference-call-to-discuss-first-quarter-financial-results-301236702.html
SOURCE Covalon Applied sciences Ltd.